Records 1 - 5
| Prognostic value of baseline genetic features and newly identified TP53 mutations in advanced breast cancer.
Molecular oncology 2022 Jul .
Zhang Lanxin, Sun Siwen, Zhao Xiaotian, Liu Jingwen, Xu Yang, Xu Lingzhi, Song Chen, Li Na, Yu Jing, Zhao Shanshan, Yu Peiyao, Fang Fengqi, Xie Jiping, Ji Xuening, Yu Ruoying, Ou Qiuxiang, Zhao Zuowei, Li M
| Association of Pathway Mutations With Survival in Taiwanese Breast Cancers.
Frontiers in oncology 2022 12 819555.
Yang Po-Sheng, Chao Ying-Ting, Lung Chun-Fan, Liu Chien-Liang, Chang Yuan-Ching, Li Ker-Chau, Hsu Yi-Chiu
| Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Breast cancer research : BCR 2018 Aug 20 (1): 88.
Liang Xu, Vacher Sophie, Boulai Anais, Bernard Virginie, Baulande Sylvain, Bohec Mylene, Bièche Ivan, Lerebours Florence, Callens Céli
| Comprehensive DNA Methylation and Extensive Mutation Analyses of HER2-Positive Breast Cancer.
Oncology 2015 88 (6): 377-84.
Yamaguchi Takeshi, Mukai Hirofumi, Yamashita Satoshi, Fujii Satoshi, Ushijima Toshika
| Notch1 single nucleotide polymorphism rs3124591 is associated with the risk of development of invasive ductal breast carcinoma in a Chinese population.
International journal of clinical and experimental pathology 2014 7 (7): 4286-94.
Cao Yu-Wen, Wan Guo-Xing, Zhao Chun-Xia, Hu Jian-Ming, Li Li, Liang Wei-Hua, Li Wen-Qin, Li Yu-Cong, Li Yi-Xiao, Du Xiao-Ming, Yu Shi-Ying, Li Fe